| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 637,256 | 561,696 | 621,266 | 800,121 | | Cost of Revenue | 376,799 | 393,520 | 382,858 | 644,264 | | | Gross Profit | 260,457 | 168,176 | 238,408 | 155,857 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 211,012 | 199,128 | 202,064 | 222,187 | | Non Recurring | 719 | 822 | 813 | (6,462) | | Others | 33,117 | 35,914 | 33,340 | 36,248 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,609 | (67,688) | 2,191 | (96,116) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | 1,636 | 97 | 2,426 | | Earnings Before Interest And Taxes | 15,632 | (66,052) | 2,288 | (93,690) | | Interest Expense | 12,831 | 12,345 | 10,435 | 9,336 | | Income Before Tax | 2,801 | (78,397) | (8,147) | (103,026) | | Income Tax Expense | (3,532) | (23,908) | (3,266) | (36,451) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,333 | (54,489) | (4,881) | (66,575) | | | Non-recurring Events | | Discontinued Operations | (15) | (23) | (236) | (32,179) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,318 | (54,512) | (5,117) | (98,754) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,318 | ($54,512) | ($5,117) | ($98,754) |
|
1.52% Nasdaq 0.00%
Income Statement
